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Abstract
Background: The misdiagnosis of Plasmodium knowlesi by microscopy has prompted a re-evaluation of the
geographic distribution, prevalence and pathogenesis of this species using molecular diagnostic tools. In this
report, a specific probe for P. knowlesi, that can be used in a previously described TaqMan real-time PCR assay for
detection of Plasmodium spp., and Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and
Plasmodium ovale, was designed and validated against clinical samples.
Methods: A hydrolysis probe for a real-time PCR assay was designed to recognize a specific DNA sequence within
the P. knowlesi small subunit ribosomal RNA gene. The sensitivity, linearity and specificity of the assay were
determined using plasmids containing P. knowlesi DNA and genomic DNA of P. falciparum, P. knowlesi, P. malariae,
P. ovale and P. vivax isolated from clinical samples. DNA samples of the simian malaria parasites Plasmodium
cynomolgi and Plasmodium inui that can infect humans under experimental conditions were also examined
together with human DNA samples.
Results: Analytical sensitivity of the P. knowlesi-specific assay was 10 copies/μL and quantitation was linear over a
range of 10-10
6 copies. The sensitivity of the assay is equivalent to nested PCR and P. knowlesi DNA was detected
from all 40 clinical P. knowlesi specimens, including one from a patient with a parasitaemia of three parasites/μLo f
blood. No cross-reactivity was observed with 67 Plasmodium DNA samples (31 P. falciparum,2 3P. vivax, six P. ovale,
three P. malariae, one P. malariae/P. ovale, one P. falciparum/P. malariae, one P. inui and one P. cynomolgi) and four
samples of human DNA.
Conclusions: This test demonstrated excellent sensitivity and specificity, and adds P. knowlesi to the repertoire of
Plasmodium targets for the clinical diagnosis of malaria by real-time PCR assays. Furthermore, quantitation of DNA
copy number provides a useful advantage over other molecular assays to investigate the correlation between
levels of infection and the spectrum of disease.
Background
The sensitivity and specificity of a diagnostic test define
the extent to which a pathogen can be effectively identi-
fied in a patient specimen. For malaria, the examination
of thin and thick blood smears by microscopy has been
the gold standard diagnostic method for over a century.
This test is simple to perform, requires only a micro-
scope and has a sensitivity of 50 parasites/μL[ 1 ] .T h e
parasitaemia can be quantified and the species of Plas-
modium identified based on parasite morphology. When
read by an experienced microscopist, the four major
species of human malaria (Plasmodium falciparum,
Plasmodium vivax, Plasmodium ovale and Plasmodium
malariae) can usually be discriminated.
However, a major pitfall of microscopy was recently
identified in the failure of this method to distinguish
between the benign P. malariae species and the poten-
tially lethal primate species Plasmodium knowlesi [2].
Zoonotic transmission of P. knowlesi from monkeys to
humans was previously only observed in sporadic cases
[3,4] and by blood passage from monkeys to humans
in laboratory controlled experiments [5-7] but was not
routinely detected by microscopic analysis of patient
specimens due to morphological similarities between P.
knowlesi and P. malariae [8]. As such, P. knowlesi was
not recognized as a cause of malaria in human popula-
tions, until recently. Using molecular diagnostic tools,
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knowlesi-specific PCR primers, Singh et al [2] exam-
ined blood samples from 208 malaria patients in the
Kapit division of Malaysian Borneo, and found that
none of the cases identified as P. malariae by micro-
scopy were confirmed by PCR and 120 (58%) were
identified as P. knowlesi by PCR. These findings
initiated a number of research studies into the epide-
miological, clinical, ecological, and parasitological fac-
tors that determine the distribution and course of P.
knowlesi infection. It is now recognized that human P.
knowlesi malaria occurs in many countries in South-
East Asia, causing locally-acquired malaria and infec-
tions in travelers returning from these regions [9-17].
Of significant concern, approximately 1 in 10 P. know-
lesi infections lead to severe malaria and seven deaths
have been reported from this species [18-20]. Plasmo-
dium knowlesi has a 24-hour erythrocytic cycle, which
is the shortest among the five species of Plasmodium
causing human malaria, and therefore correct identifi-
cation and rapid treatment are essential, particularly
when the parasitaemia is high.
Given the potential for misdiagnosis of P. knowlesi by
microscopy, alternative diagnostic tests must be
employed to confirm this infection. Rapid diagnostic
tests from two manufacturers have been evaluated for
detection of P. knowlesi antigens. Cross-reactivity was
observed with both P. falciparum and P. vivax antigens,
precluding the use of these tests for rapid diagnosis
[21]. Molecular diagnostics for detection of P. knowlesi
include nested PCR and/or sequencing [2,22], LAMP
[23], and real-time PCR [24]. In clinical diagnostic and
reference laboratories, particularly those in developed
countries, real-time PCR is the method of choice by
providing superior sensitivity, rapid results and low risk
of false positives. It is also far less laborious than nested
PCR, enabling high throughput screening of patient
samples. A number of real-time PCR assays have been
developed for malaria diagnosis but these can only
detect P .f a l c i p a r u m ,P .v i v a x ,P .m a l a r i a ea n dP .o v a l e
[25-31]. Only one assay has been reported for detection
of P. knowlesi by real-time PCR [24]. However, the vali-
dation of this assay was limited to 2 reference DNA
samples from infections in monkeys and no human clin-
ical samples were tested. In the current report, a real-
time PCR assay for P. knowlesi was developed and vali-
dated with clinical samples from 40 patients infected
with P. knowlesi.T h eP. knowlesi assay developed uses
the same reaction conditions of the real-time PCR assay
described by Rougemount et al that screens for Plasmo-
dium and identifies P. falciparum, P. vivax, P. malariae
and P. ovale using species-specific probes [30].
Methods
Samples
Whole blood samples were collected from patients
admitted with malaria to Kapit Hospital, Sarawak from
July 2006 to February 2008 for a study aimed at deter-
mining the clinical and laboratory features of knowlesi
malaria [20]. Blood samples were transported in liquid
nitrogen to the Malaria Research Centre, University
Malaysia Sarawak and stored in the -80°C freezer. Para-
sitaemia was determined by examination of thick blood
films by two experienced microscopists from the
Malaria Research Centre, University Malaysia Sarawak
and the Sarawak Health Department. The parasitaemia
was estimated by counting the number of parasites per
500 white blood cells and then calculating the parasite
counts from the total number of white blood cells per
μL blood for each patient. The mean of the two parasi-
taemia for each sample was used in the data analysis.
Forty patient samples with single P. knowlesi infections
were randomly selected for this study [20]. Of these, 26
(65%) had a parasitaemia below 500 parasites per μL
blood and the rest ranged from 500 to 28,000 parasites
per μL blood. Genomic DNA of P. falciparum (2 sam-
ples), P. vivax (4 samples), P. ovale (1 sample) and P.
malariae (1 sample) were obtained from patients at
Kapit Hospital. Plasmodium species in all patient sam-
ples were identified and confirmed by nested PCR assays
[2]. The collection and testing of blood samples was
approved by the Medical Research and Ethics Commit-
tee of the Malaysian Ministry of Health. Genomic DNA
samples of Plasmodium cynomolgi and Plasmodium inui
were obtained from the Biomedical Primate Research
Centre, Rijswijk, the Netherlands. To determine the spe-
cificity of the P. knowlesi probe, an additional 57 sam-
ples (29 P. falciparum,1 9P. vivax,f i v eP. ovale,t w oP.
malariae,o n eP. malariae/P. ovale and one P. falci-
parum/P. malariae) from the Provincial Laboratory for
Public Health in Canada were tested from patients with
acute malaria using the ABI 7500 platform. These sam-
ples were tested with approval from the Health Research
Ethics Board of the University of Alberta.
Plasmid DNA
Part of the 18S rRNA gene of P. knowlesi KH33 (acces-
sion number AY327549) was cloned into pCR®-Blunt
vector (Invitrogen, USA) and verified by DNA sequen-
cing. The concentration of plasmid DNA was deter-
mined by spectrophotometer for the calculation of the
DNA copy number. For standard curve analysis in real-
time PCR assays, the plasmid was diluted 10-fold in
nuclease free water from 10
6 copies to 1 copy per μL.
Threshold cycle (Ct) values in real-time PCR assays
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duced by the dilutions of plasmid DNA.
DNA extraction
Whole blood samples were equilibrated at room tem-
perature and 200 μL of blood was used for DNA extrac-
tion. Genomic DNA was extracted according to the
spin-column method using the QIAamp DNA Blood
Mini Kit, as per the manufacturer’s instructions (Qiagen,
Germany) and eluted in a total volume of 200 μLf o r
each sample.
Nested PCR
The identification of Plasmodium species was performed
by nested PCR as described previously [2]. For the first
round of amplification, part of the 18 S rRNA gene was
amplified using primers rPLU1 and rPLU5, which gener-
ates an amplicon of approximately 1650 bp in length. The
determination of Plasmodium species was carried out in
the second nested amplification reaction for the identifica-
tion of P. falciparum (primers rFAL1, rFAL2), P. vivax
(rVIV1, rVIV2), P. ovale (rOVA1, rOVA4), P. malariae
(rMAL1, rMAL2) and P. knowlesi (Pmk8, Pmkr9).
Real-time PCR
Real-time PCR was performed using TaqMan chemistry
and hydrolysis probes. Two separate reactions were per-
formed: 1) a screening reaction for the detection of all
Plasmodium species, and 2) a specific reaction for the
detection of P. knowlesi.B o t hr e a c t i o n su s et h es a m e
primers (Plasmo 1 and 2), but distinct probes (Plasprobe
and Pk probe), were utilised for screening and P. know-
lesi identification, respectively. DNA sequences for the
primers Plasmo 1 and 2 and the Plasmodium screening
probe, Plasprobe, were reported previously [30]. The
sequence of the probe specific for P. knowlesi, Pk probe,
is the following: 5’-CTCTCCGGAGATTAGAACTCT-
TAGATTGCT-3’. Both Plasprobe and Pk probe were
labelled with the fluorophore FAM on the 5’ end with a
black hole quencher BHQ-1 on the 3’ end. Primers were
s y n t h e s i z e db yI n t e g r a t e dD N AT e c h n o l o g i e s( I o w a ,
USA) and probes by Biosearch Technologies, Inc.
(Novato, CA, USA). The real-time PCR reaction con-
sisted of 200 nM of each primer, 80 nM of probe, 12.5
μL TaqMan Universal Master Mix (Applied Biosystems,
USA), and 5 μLo fD N Ai na2 5μL volume. Reactions
were performed on the Mastercycler® ep realplex plat-
form (Eppendorf, Germany) at the University Malaysia
Sarawak, and on the ABI 7500 platform (Applied Biosys-
tems, USA) at the Provincial Laboratory for Public
Health in Canada, with the following cycling conditions:
50°C for 2 min, initial denaturation at 95°C for 10 min,
and 45 cycles of 95°C for 15 sec and 60°C for 1 min.
Fluorescence data was collected during the annealing/
extension step at 60°C. Cycle threshold (Ct) values were
analysed either by setting the threshold 10 times the
standard deviation above the noise of baseline or adjust-
ing the standard curve to optimum. The baseline was
determined manually between cycles 3 and 15.
Statistical analyses
Data were analysed using SPSS software, version 17.0.
The strengths of the linear relationship between loga-
rithms of mean parasitaemia and Ct values for each
probe were measured using the Pearson correlation
coefficient. In this study, a negative correlation between
parasitaemia and the Ct values due to the influence of
parasite DNA copy numbers was hypothesized.
Results
Assay design
A real-time PCR assay for P. knowlesi was developed
that is complementary to the Plasmodium screening
assay published by Rougemont et al for P. falciparum,
P. vivax, P. ovale and P. malariae [30]. Their assay
enables rapid screening of patient specimens for Plasmo-
dium and has been implemented within clinical diagnos-
tic laboratories for confirmation of the species of
Plasmodium [32,33]. The assay uses primers that bind
to DNA sequences within the 18 S rRNA gene that are
highly conserved across Plasmodium species. Detection
with the TaqMan hydrolysis probe, Plasprobe, recog-
n i z e sa l ls p e c i e so fPlasmodium that infect humans,
including P. knowlesi [30,33]. In addition to the Plasmo-
dium screening assay, the same primers can be used
with species-specific probes that bind to a variable
region within the target sequence. A P. knowlesi-specific
probe was designed in the current study, called Pk
probe, to bind specifically to a 30 base pair sequence
within this variable region. Of the other human Plasmo-
dium species, P. vivax shares the most homology with
this sequence, however only 23/30 bases are predicted
to bind the Pk probe. Two primate species, P. cynomolgi
and P. inui, share 26/30 and 25/30 sequence matches,
respectively, and were therefore included in subsequent
experiments to determine the specificity of the probe. A
BLAST search using the Pk probe sequence did not
identify any potential cross-reactivity with other patho-
gens or human DNA.
Analytical validation of the P. knowlesi assay
To determine the analytical sensitivity of the assay, the
limit of detection was identified using a plasmid con-
taining part of the 18 S rRNA gene from P. knowlesi.
Ten-fold serial dilutions of this plasmid were prepared
and served as the template in both the Plasprobe and Pk
probe real-time PCR assays (Table 1). Based on the
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sitive in detecting the target DNA sequence compared
with the Plasprobe. This was observed in all dilutions
tested. Despite this, the limit of detection was 10 copies
of template per PCR reaction for both real-time assays
and the efficiencies of the two PCR reactions were very
similar (94% for Plasprobe and 95% for Pk probe). Both
assays were linear between 10 and 10
6 copies of tem-
plate DNA.
The dynamic range of the assay was determined using
serial dilutions of genomic DNA extracted from a
patient sample infected with P. knowlesi (Table 1). As
observed with the plasmid DNA, the Pk probe reaction
had lower Ct values, yet the overall sensitivity of the
two assays was similar. Both real-time PCR assays
detected P. knowlesi template over a dynamic range of 5
log dilutions.
Specificity for P. knowlesi
Plasmodium knowlesi has been largely overlooked as a
human pathogen because it was identified mainly as
P. malariae in blood films by microscopy. However,
nested PCR revealed the widespread distribution of this
parasite in human populations based on its ability to dis-
tinguish genetic variations between this species and other
human malarias [2]. To determine the specificity of the Pk
probe, a number of genomic DNA templates extracted
from patients infected with other species of Plasmodium
(Table 2) were tested. No cross-reactivity was observed for
DNA samples from patients with P. vivax, P. falciparum,
P. malariae and P. ovale infections. Similar negative
results were obtained with the Pk probe when 57 clinical
samples from malaria patients were examined at the Pro-
vincial Laboratory for Public Health, Edmonton, Canada
with the ABI 7500 platform. Furthermore, genomic DNA
from two other primate species of Plasmodium, P. cyno-
molgi and P. inui, that have the potential to cause zoo-
noses [34] were examined. Both of these species were
detected using the Plasprobe, but neither was detected
with the Pk probe (Table 2).
Validation with clinical samples from patients infected
with P. knowlesi
To evaluate the accuracy of the real-time PCR assay, 40
blood samples from patients infected with P. knowlesi
were examined. Samples were tested alongside gDNA
extracted from patients infected with other species of
Plasmodium (described above) and five uninfected sam-
ples as negative controls. For all samples, nested PCR
served as the gold standard test. The panel was tested
blind. All P. knowlesi samples were positive with both
the Plasprobe and Pk probe by real-time PCR, including
a sample with a parasitaemia as low as 3 parasites/μL
(Figure 1). As observed with plasmid DNA, the Ct
values were lower for the Pk probe than the Plasprobe,
but the overall sensitivity was 100% for both assays.
Quantitation of the template copy number by real-time
PCR demonstrated increased concentrations of parasite
DNA with higher parasitaemic infections. There was a
significant negative correlation between Ct values and
parasitaemia (p < 0.01, Pearson correlation) for both the
Plasprobe (Figure 1A) and the Pk probe (Figure 1B).
Quantitative analysis of parasite DNA from clinical sam-
ples had a detection limit of 33 DNA copies/μL, corre-
sponding to fewer than 6 parasites.
Discussion
In this report, the validation of a real-time PCR assay with
a specific probe designed to detect P. knowlesi is described.
The analytical sensitivity of the test is 10 copies per PCR;
given the multicopy nature of the rRNA gene in Plasmo-
dium [35,36], this corresponds to approximately 1-2 para-
site genomes. This sensitivity was corroborated with
clinical samples that were detected by real-time PCR, even
at a parasitaemia of 3 parasites/μLo fb l o o d .
The assay also demonstrated excellent specificity for
P. knowlesi. No cross-reactivity was observed with other
Plasmodium species, including two closely related pri-
mate species P. cynomolgi and P. inui. The specificity is
of particular importance given the historical misdiagno-
sis of P. knowlesi by microscopy. Only with the availabil-
ity of molecular methods can the prevalence of this
species be confirmed in human populations. However,
molecular techniques can also be subject to specificity
Table 1 Detection of P. knowlesi target gene in plasmid
KH33 and genomic DNA
Template Concentration Plasprobe
Ct*
Pk probe
Ct*
Plasmid (copies/μL) 1 × 10
6 23.3 20.5
1×1 0
5 26.7 23.6
1×1 0
4 30.3 27.7
1×1 0
3 34.1 31.0
1×1 0
2 37.6 34.4
10 40.3 37.5
1N D ‡ ND‡
gDNA†(parasites/μL
blood)
4480 26.7 25.6
480 28.5 27.4
48 32.2 31.1
4.8 35.8 34.7
0.48 40.2 38.8
0.048 42.4 39.5
0.0048 ND‡ ND‡
*Cycle threshold.
†Genomic DNA extracted from a clinical sample with single P. knowlesi
infection.
‡ND, not detected.
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mers used to detect P. knowlesi by nested PCR spur-
iously amplify a proportion of P. vivax genomic DNA
samples, resulting in false positive results for P. knowlesi
[22,37]. In the real-time PCR assay described, one set of
primers amplifies all five species of Plasmodium but
specificity is achieved through the design of the hydroly-
sis probe. This was supported experimentally, as no
cross-reactivity of the Pk probe was observed with DNA
from 65 clinical specimens infected with Plasmodium
species other than P. knowlesi,i n c l u d i n g2 3P. vivax
DNA samples. However, competition for the conserved
primers may compromise the sensitivity of detection for
mixed infections with P. knowlesi.
The P. knowlesi assay developed uses the same reac-
t i o nc o n d i t i o n so fap r e v i o u s l yp u b l i s h e dr e a l - t i m eP C R
a s s a yb yR o u g e m o u n tet al that screens for all human
species of Plasmodium and identifies the species using
specific probes [30,33]. The real-time assay by Rouge-
mount et al has been successfully implemented in two
provincial public health laboratories in Canada using the
ABI 7500 and 7900 platforms [32,33]. In the current
study, validation for the Plasprobe and Pk probe reac-
tions was performed on the Eppendorf platform with no
loss in sensitivity compared with the ABI systems. The
versatility of this test for different real-time PCR plat-
forms is an advantage for clinical diagnostic laboratories
implementing this methodology for malaria species con-
firmation. Other general advantages of real-time PCR
include the low risk of contamination and rapid, auto-
mated processing, enabling high throughput diagnostic
testing. For malaria, this test can be readily employed to
evaluate patient samples that are positive for Plasmo-
dium but unidentified at the species level. Samples can
also be tested with the Pk probe alongside the multiplex
assay for the other four species to investigate potential
mixed infections [33]. Furthermore, quantitation of
P. knowlesi DNA copy number by real-time PCR
Table 2 Assay specificity for P. knowlesi
Sample Code Identification by nested PCR assay Plasprobe Ct* Pk probe Ct*
MISC23 P. vivax 31.2 ND†
CDK123 P. vivax 30.7 ND†
CDK118 P. vivax 27.6 ND†
SKS358 P. vivax 26.7 ND†
KH116 P. falciparum 25.1 ND†
CDK135 P. falciparum 26.7 ND†
CDK67 P. malariae 37.0 ND†
KH352 P. ovale 26.5 ND†
P. cynomolgi Plasmodium-positive 15.0 ND†
P. inui Plasmodium-positive 13.0 ND†
*Cycle threshold.
†ND, not detected.
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Figure 1 Correlation between Ct value and parasitaemia.L o g
parasitaemia values (parasites/μL blood) were plotted against Ct
values from the Plasprobe (A) and Pk probe (B) PCR reactions, for 40
blood samples infected with P. knowlesi.
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to the parasitaemia calculated from a blood smear.
Quantitative analysis of parasitaemia by real-time PCR
can be correlated with the clinical presentation of dis-
ease to better understand the pathogenesis of this spe-
cies in the human host.
Conclusions
This study reports the analytical and clinical validation
o fan e wr e a l - t i m eP C Ra s s a yf o rP. knowlesi based on
TaqMan technology. The assay demonstrated excellent
sensitivity, linearity and specificity with plasmid DNA
and genomic DNA isolated from patients infected with
P. knowlesi. This diagnostic tool can be useful for pro-
spective and retrospective analysis of samples for sur-
veillance and epidemiological studies. The impact of the
under-diagnosis of P. knowlesi by microscopy is of glo-
bal concern and rapid screening tools that can process
archived samples will be invaluable to reassess the geo-
graphical distribution of this species.
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